Iron overload of the bone marrow by trimethylhexanoyl-ferrocene in rats.
Iron-deficient female Wistar rats were fed a diet which contained 0.5% 3,5,5-trimethylhexanoyl (TMH)-ferrocene over a 57-week period. The state of iron deficiency was characterized by means of the absence of stainable iron in the bone marrow. After the first days on the iron-enriched diet, ferritin-containing siderosomes were found, in numerous erythroblasts up to orthochromatic normoblasts and in reticulocytes, i.e. the dispensed iron was used for haemoglobin synthesis. After 1 week the first macrophages showed a positive Perls' Prussian blue reaction. In the cytoplasm they stored the iron in the form of free ferritin molecules and lysosomally as aggregated ferritin and/or haemosiderin. The iron loading of the macrophages increased in both of the storage qualities proportionally with duration of the feeding period and reached a maximum after 38 weeks. Final stages showed extremely iron-loaded macrophages with high concentrations of free ferritin molecules and large siderosomes, partially flowing together to still greater units. Iron deposits within endothelial cells of bone marrow sinusoids can be observed for the first time after 4 weeks. In these cells the iron is stored as ferritin in siderosomes of relatively small and uniform size; free ferritin molecules in the cytosol were of only slight concentration. The TMH-ferrocene model of iron overload shows in the bone marrow: (1) an unimpeded utilization of the iron component for erythropoiesis, (2) development of excessive iron overload of the bone marrow in macrophages and endothelial cells of sinusoids and (3) a pattern of distribution of iron as seen in secondary haemochromatosis.
Braumann
A
A
Anatomisches Institut, Universität Bonn, BRD.
Wulfhekel
U
U
Düllmann
J
J
Nielsen
P
P
D000747:Anemia, Hypochromic / Q000209:etiology / Q000378:metabolism*; D000818:Animals; D001853:Bone Marrow / Q000378:metabolism*; D004195:Disease Models, Animal; D004727:Endothelium / Q000166:cytology / Q000378:metabolism; D004900:Erythroblasts / Q000378:metabolism; D005260:Female; D005293:Ferritins / Q000032:analysis* / Q000378:metabolism; D005296:Ferrous Compounds / Q000008:administration & dosage / Q000493:pharmacokinetics*; D008264:Macrophages / Q000378:metabolism; D000075163:Metallocenes; D008854:Microscopy, Electron; D009942:Organometallic Compounds / Q000008:administration & dosage / Q000493:pharmacokinetics*; D051381:Rats; D017208:Rats, Wistar
D005296:Ferrous Compounds; D000075163:Metallocenes; D009942:Organometallic Compounds; D005293:Ferritins; C004998:ferrocene